Status:
COMPLETED
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
Lead Sponsor:
Alaska Native Tribal Health Consortium
Collaborating Sponsors:
Mayo Clinic
Yukon Kuskokwim Health Corporation
Conditions:
Colorectal Cancer
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Only 59% of Alaska Native people have been adequately screened for colorectal cancer (CRC) despite having the highest reported incidence of CRC in the world. A new at-home multi-target stool DNA scree...
Detailed Description
The study will employ a cluster-randomized design, in which 32 communities within one Tribal health region will be randomized to one of the two study intervention conditions, matched by community size...
Eligibility Criteria
Inclusion
- Alaska Native adults eligible to receive health care through the Alaska Tribal Health System
- Active health system users with at least one Alaska Tribal Health System visit in the previous three years
- Due for colorectal cancer screening (have not had colonoscopy in past 10 years or fecal occult blood test in past 1 year or flexible sigmoidoscopy in past 5 years)
Exclusion
- First-degree relative diagnosed with CRC at age 60 or younger
- History of familial adenomatous polyposis
- Hereditary non-polyposis CRC
- Previous colonoscopic evidence of inflammatory bowel disease, Crohn's disease, colorectal adenomas, or CRC
- Known history of colectomy
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2024
Estimated Enrollment :
2029 Patients enrolled
Trial Details
Trial ID
NCT04336397
Start Date
April 29 2021
End Date
September 15 2024
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yukon-Kuskokwim Health Corporation
Bethel, Alaska, United States, 99559